Global Neuroscience Antibodies and Assays Market to Reach $8.8 Billion by 2030
The global market for Neuroscience Antibodies and Assays estimated at US$4.4 Billion in the year 2022, is projected to reach a revised size of US$8.8 Billion by 2030, growing at a CAGR of 8.9% over the analysis period 2022-2030. Consumables, one of the segments analyzed in the report, is projected to record 9.3% CAGR and reach US$5.9 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Instruments segment is readjusted to a revised 8.2% CAGR for the next 8-year period.The U.S. Market is Estimated at $1.3 Billion, While China is Forecast to Grow at 8.3% CAGR
The Neuroscience Antibodies and Assays market in the U.S. is estimated at US$1.3 Billion in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$1.5 Billion by the year 2030 trailing a CAGR of 8.3% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 8.3% and 7.2% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 7.2% CAGR.Select Competitors (Total 11 Featured) -
- Abcam PLC
- BioLegend, Inc.
- Bio-Rad Laboratories, Inc.
- Cell Signaling Technology, Inc.
- F. Hoffmann-La Roche AG
- GenScript Biotech Corporation
- Merck KgaA
- Rockland Immunochemicals, Inc.
- Santa Cruz Biotechnology, Inc.
- Siemens Healthineers
- Tecan Group Ltd.
- Thermo Fisher Scientific, Inc.
What's New?
- Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
- Global competitiveness and key competitor percentage market shares
- Market presence across multiple geographies - Strong/Active/Niche/Trivial
- Online interactive peer-to-peer collaborative bespoke updates
- Access to digital archives and Research Platform
- Complimentary updates for one year
Table of Contents
I. METHODOLOGYII. EXECUTIVE SUMMARY2. FOCUS ON SELECT PLAYERS3. MARKET TRENDS & DRIVERSIV. COMPETITION
1. MARKET OVERVIEW
4. GLOBAL MARKET PERSPECTIVE
III. MARKET ANALYSIS
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Abcam PLC
- BioLegend, Inc.
- Bio-Rad Laboratories, Inc.
- Cell Signaling Technology, Inc.
- F. Hoffmann-La Roche AG
- GenScript Biotech Corporation
- Merck KgaA
- Rockland Immunochemicals, Inc.
- Santa Cruz Biotechnology, Inc.
- Siemens Healthineers
- Tecan Group Ltd.
- Thermo Fisher Scientific, Inc.
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 179 |
Published | March 2024 |
Forecast Period | 2022 - 2030 |
Estimated Market Value ( USD | $ 4.4 Billion |
Forecasted Market Value ( USD | $ 8.8 Billion |
Compound Annual Growth Rate | 9.1% |
Regions Covered | Global |